−£91
−100%vs Dec 2024Active10555293Private limited companyOxford
BERGENBIO LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Bergenbio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Bergenbio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BERGENBIO LIMITED is an active private limited company (company number 10555293) incorporated on 10 January 2017, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£91 and cash of £16k, with 5 employees on average. Net assets fell 100% on the prior period (£22k).
Peer position · net assets
By net assets it sits in the lower half of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
No active person with significant control is registered.
- Bergenbio Asa
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 10 January 20179 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 24 January 2027in 91 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£16k
−96%vs Dec 2024Not reported
5
−50%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£91 | £16k | — | £21k | — | — | 5 |
| 31 December 2024 | £22k | £388k | — | £617k | — | — | 10 |
Current ratio1Current assets ÷ creditors within one year
Cash per employee£3,142Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-91 at 31 December 2025
- Net assets down 25% or more on the prior period-100.4% vs prior period
- Incorporated five or more years agoIncorporated 10 January 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 91 days
- Accounts period endNet liabilities £91 · small accounts
- Accounts period endNet assets £22k · small accounts
- Incorporated
08
Similar companies in Oxford
- OXFORD MEDICAL PRODUCTS LIMITEDWitney · inc. Dec 2016
- PATHIOS THERAPEUTICS LIMITEDAbingdon · inc. Feb 2017
- SPYBIOTECH LIMITEDOxford · inc. Mar 2017
- ENARA BIO LIMITEDOxford · inc. Nov 2016
- SITRYX THERAPEUTICS LIMITEDOxford · inc. Sept 2016
- GENOMEX LTDOxford · inc. Sept 2016
All companies incorporated on 10 January 2017 · in Jan 2017.
09
Reminders for BERGENBIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.